Business Description
UnitedHealth Group Inc
NAICS : 524114
SIC : 6324
ISIN : US91324P1021
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.44 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.8 | |||||
Debt-to-EBITDA | 2.53 | |||||
Interest Coverage | 9.65 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.01 | |||||
Beneish M-Score | -2.36 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14 | |||||
3-Year EBITDA Growth Rate | 13.7 | |||||
3-Year EPS without NRI Growth Rate | 16.2 | |||||
3-Year FCF Growth Rate | 9.4 | |||||
3-Year Book Growth Rate | 11.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12.93 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
12-1 Month Momentum % | 9.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.85 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.31 | |||||
Days Sales Outstanding | 21.07 | |||||
Days Payable | 72.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.48 | |||||
Dividend Payout Ratio | 0.29 | |||||
3-Year Dividend Growth Rate | 14.7 | |||||
Forward Dividend Yield % | 1.48 | |||||
5-Year Yield-on-Cost % | 3.11 | |||||
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | 1.28 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 24.05 | |||||
Operating Margin % | 8.49 | |||||
Net Margin % | 4.05 | |||||
FCF Margin % | 2.77 | |||||
ROE % | 17.89 | |||||
ROA % | 5.47 | |||||
ROIC % | 9.77 | |||||
ROC (Joel Greenblatt) % | 231.66 | |||||
ROCE % | 14.66 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 30.1 | |||||
Forward PE Ratio | 17.67 | |||||
PE Ratio without NRI | 19.11 | |||||
Shiller PE Ratio | 32.28 | |||||
Price-to-Owner-Earnings | 143.53 | |||||
PEG Ratio | 1.41 | |||||
PS Ratio | 1.21 | |||||
PB Ratio | 4.91 | |||||
Price-to-Tangible-Book | 4.91 | |||||
Price-to-Free-Cash-Flow | 44.1 | |||||
Price-to-Operating-Cash-Flow | 33.32 | |||||
EV-to-EBIT | 19.67 | |||||
EV-to-Forward-EBIT | 13.88 | |||||
EV-to-EBITDA | 16.97 | |||||
EV-to-Forward-EBITDA | 12.5 | |||||
EV-to-Revenue | 1.3 | |||||
EV-to-Forward-Revenue | 1.24 | |||||
EV-to-FCF | 46.98 | |||||
Price-to-Projected-FCF | 1.38 | |||||
Price-to-DCF (Earnings Based) | 0.71 | |||||
Price-to-DCF (FCF Based) | 1.62 | |||||
Price-to-Median-PS-Value | 1.07 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.68 | |||||
Price-to-Graham-Number | 2.04 | |||||
Earnings Yield (Greenblatt) % | 5.08 | |||||
FCF Yield % | 2.32 | |||||
Forward Rate of Return (Yacktman) % | 15.67 |